Daesung Microbiological Labs. Co. Ltd (036480) — Cash Flow Quality Index
Daesung Microbiological Labs. Co. Ltd (036480) has a Cash Flow Quality Index of 4.00x as of December 2025. Operating cash flow of ₩972.26 Million exceeds net income of ₩243.19 Million, indicating high earnings quality where cash backs reported profits. Explore 036480 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Daesung Microbiological Labs. Co. Ltd Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Daesung Microbiological Labs. Co. Ltd generate cash.
Annual Cash Flow Quality Index for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year earnings quality comparison for Daesung Microbiological Labs. Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | ₩1.41 Billion | ₩598.19 Million | ▲ +247.5% |
| 2022 | 0.68x | ₩1.16 Billion | ₩1.70 Billion | ▼ -73.3% |
| 2021 | 2.54x | ₩2.20 Billion | ₩865.92 Million | ▲ +19.4% |
| 2020 | 2.13x | ₩3.24 Billion | ₩1.52 Billion | ▲ +162.3% |
| 2019 | 0.81x | ₩2.32 Billion | ₩2.85 Billion | ▼ -17.9% |
| 2018 | 0.99x | ₩3.14 Billion | ₩3.17 Billion | ▼ -8.3% |
| 2017 | 1.08x | ₩1.68 Billion | ₩1.56 Billion | ▲ +37.7% |
| 2016 | 0.78x | ₩3.52 Billion | ₩4.49 Billion | ▼ -53.5% |
| 2015 | 1.68x | ₩7.66 Billion | ₩4.55 Billion | ▼ -10.3% |
| 2014 | 1.88x | ₩3.83 Billion | ₩2.04 Billion | ▼ -57.0% |
| 2013 | 4.36x | ₩1.89 Billion | ₩433.00 Million | ▼ -16.6% |
| 2012 | 5.23x | ₩2.33 Billion | ₩446.00 Million | — |